May 25, 2024

Blepharitis Treatment Market Trends its way to Growth with Enhanced Diagnosis and Awareness

Blepharitis is an inflammatory condition of the eyelids that can cause them to become red, scratchy, and swollen. Symptoms include irritation, eyelid scaling or crusting, and eyelashes that appear matted. Blepharitis occurs when the oil glands in the eyelids become clogged or there is an overproduction of bacteria on the eyelid. Effective treatment options for blepharitis include eyelid scrubs, warm compresses, antibiotic ointments or drops, lid scrubs and artificial tears. The growing prevalence of ocular surface infections along with the rising awareness regarding eye care are the key factors expected to drive the growth of the global blepharitis treatment market over the forecast period.

The global blepharitis treatment market is estimated to be valued at US$ 2.5 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period of 2023 to 2030.

Key Takeaways
Key players operating in the blepharitis treatment market are Scope Ophthalmic Ltd., NovaBay Pharmaceuticals Inc., Thea Pharmaceuticals Ltd., Perrigo Laboratories, InSite Vision Incorporated, Merck & Co., and Novartis AG. Key players are focusing on research and development activities to develop innovative and effective treatment options for blepharitis.

The growing prevalence of ocular infections and rising awareness regarding eye disorders has propelled the demand for blepharitis treatment products. According to a recent study, blepharitis affects nearly 25% of the global population leading to rising adoption of treatment options.

Geographical expansion through partnerships and collaborations is helping key players strengthen their global footprint. Manufacturers are also focusing on emerging markets in Asia Pacific and Latin America for business expansion opportunities due to increasing healthcare expenditure and growing medical tourism in these regions.

Market key trends
Early diagnosis of blepharitis plays a crucial role in effective management of the condition. Technologies facilitating easy, non-invasive and faster diagnosis such as smartphone-based microscopes are gaining popularity. These devices enable examination of eyelashes and diagnosis of blepharitis through high-resolution digital images. Additionally, increasing online availability of information is enhancing awareness regarding early symptom recognition and treatment options for blepharitis management.

Porter’s Analysis

Threat of new entrants: Low barriers for new competitors to enter the blepharitis treatment market due to knowledge available for developing drugs and therapies.

Bargaining power of buyers: Moderate bargaining power for buyers as blepharitis treatment options are available from multiple manufacturers.

Bargaining power of suppliers: Suppliers have low bargaining power due to availability of alternate raw material sources and manufacturing suppliers.

Threat of new substitutes: Low threat of new substitutes as blepharitis has limited treatment options currently available.

Competitive rivalry: High competitive rivalry between existing players to gain higher market share.

Geographical Regions

North America region accounts for the largest share of the global blepharitis treatment market currently due to higher awareness levels and developed healthcare infrastructure in the region.

Asia Pacific region is expected to witness the fastest growth during the forecast period owing to increasing initiatives by governments and healthcare organizations to spread awareness about blepharitis treatment options in densely populated countries like China and India.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it